BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
76.18
-0.50 (-0.65%)
Apr 21, 2026, 4:00 PM EDT - Market closed
BridgeBio Pharma Analyst Ratings
Total Analysts
25
Consensus Rating
Strong Buy
Price Target
$86.04
Upside
+12.94%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Initiates $100 | Buy | Initiates | $100 | +31.27% | Apr 9, 2026 |
| Mizuho | Mizuho | Buy Maintains $91 → $106 | Buy | Maintains | $91 → $106 | +39.14% | Mar 18, 2026 |
| JP Morgan | JP Morgan | Buy Maintains $89 → $94 | Buy | Maintains | $89 → $94 | +23.39% | Mar 10, 2026 |
| William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Mar 10, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $86 → $95 | Strong Buy | Maintains | $86 → $95 | +24.70% | Feb 25, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $83 → $81 | Buy | Maintains | $83 → $81 | +6.33% | Feb 25, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $96 → $98 | Buy | Maintains | $96 → $98 | +28.64% | Feb 25, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $100 → $125 | Buy | Maintains | $100 → $125 | +64.09% | Feb 25, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $90 → $100 | Strong Buy | Maintains | $90 → $100 | +31.27% | Feb 17, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $81 → $83 | Buy | Maintains | $81 → $83 | +8.95% | Feb 13, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $88 → $98 | Buy | Maintains | $88 → $98 | +28.64% | Feb 13, 2026 |
| Barclays | Barclays | Buy Initiates $80 | Buy | Initiates | $80 | +5.01% | Jan 28, 2026 |
| Wells Fargo | Wells Fargo | Buy Maintains $84 → $88 | Buy | Maintains | $84 → $88 | +15.52% | Jan 20, 2026 |
| Truist Securities | Truist Securities | Strong Buy Maintains $80 → $86 | Strong Buy | Maintains | $80 → $86 | +12.89% | Jan 8, 2026 |
| Morgan Stanley | Morgan Stanley | Buy Initiates $96 | Buy | Initiates | $96 | +26.02% | Jan 6, 2026 |
| Leerink Partners | Leerink Partners | Buy Maintains $75 → $86 | Buy | Maintains | $75 → $86 | +12.89% | Dec 15, 2025 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 10 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.